Clinical Trial Update: Management of Castration-Resistant Prostate Cancer with Oligometastases [Phase 2, Phase 3]

View source ↗

Summary

This document reports an ongoing Phase 2/Phase 3 clinical trial evaluating management of castration-resistant prostate cancer with oligometastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Castration-resistant Prostate Cancer Patients with Oligometastases | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING